Medicine guide

Hexavac

Active substance: Diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted
Used in: Antibiotics, antivirals and antifungals taken into the body
Made by: Sanofi Pasteur MSD, SNC
Source: Official label

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

This combined vaccine is indicated for primary and booster vaccination of children against diphtheria, tetanus, pertussis, hepatitis B caused by all known subtypes of viruses, poliomyelitis and invasive infections caused by Haemophilus influenzae type b.

From the official label · 2026-09-30 · European Medicines Agency

Made by	Sanofi Pasteur MSD, SNC
Active substance	Diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted
Used in	Antibiotics, antivirals and antifungals taken into the body
Classification	J07CA · Antibiotics, antivirals and antifungals taken into the body
Authorised on	2000-10-23
Last updated by the regulator	2012-08-16
EMA product number	EMEA/H/C/000298

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).